Translational Research in Clinical Oncology (TRACO)

Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation sequencing, genomics and proteomics.

The Translational Research in Clinical Oncology (TRACO) course will be held on Monday afternoons from September to December on the Bethesda campus (Building 50, ground floor auditorium). TRACO is designed to provide an overview of the general principles of cancer biology and treatment, epidemiology, genomics, precision medicine, mechanisms of resistance, use of preclinical models, and identification of novel molecular targets. Participants will have an unprecedented opportunity to learn new information, glimpse into future developments of translational research in clinical oncology, and meet leaders in cancer research. The participation of NIH postdoctoral and clinical fellows is encouraged.  .

  • There is no registration fee for this course.
  • The registration limit is 150 students.

Related Training Opportunities

This course is part of an ongoing training curriculum for NCI clinical and postdoctoral fellows. TRACO complements other topics in human diseases and therapies covered in Demystifying Medicine, which is hosted by Dr. Irwin M. Arias. Other classes offered periodically by the CCR Office of Training and Education include: Redox BiologyStatistical Analysis of Research Data ,Cancer BiotechnologyTeaching In Medical Education, and Scientific Management Training . For additional postdoctoral training opportunities at NIH visit https://www.training.nih.gov/.




Final Exam and Course Evaluation

The final exam is now closed.

Certificate

Participants who register for this course may receive a certificate of completion after attending the lectures, passing an online examination, and completing a course evaluation.


Location

Two 1-hour sessions will usually occur on Mondays, 4:00 to 6:00 pm in the Building 50 ground floor auditorium (Rooms 1227/1233) with videoconferencing to NCI at Frederick (Building 549, Room B). In addition, lectures will be videocast and archived at http://videocast.nih.gov. Each session will have two 50-minute lectures in basic and clinical sciences with ample time for discussion and analysis. A handout for each lecture will be distributed on site.  Classes will be held from Sept. 5, 2017 – Dec. 4, 2017.


Additional Activities

Course registrants can also attend NCI tumor boards, CCR Grand Rounds, and/or visit technical facilities. Please contact Dr. Moody to make appropriate reservations.


Faculty Coordinators

Irwin Arias, MD
Terry Moody, Ph.D.
Lyuba Varticovski, MD
Jonathan Wiest, Ph.D.
Farah Zia, MD

Faculty

  • C. Annunziata, MD 
  • N. Caplen, PhD
  • N. Caporaso, MD
  • H. Chen, MD, PhD
  • P. Choyke, MD   
  • M. Dobrovolskaia, PhD
  • K. Dunleavy, MD
  • S. Goff, MD 
  • C. Harris, MD
  • P. Hussain, PhD
  • S. Jakowlew, PhD
  • R. Madan, MD 
  • F. Maldarelli, MD

 

 

  • T. Moody, PhD
  • L. Neckers, PhD
  • E. Nichols, MD
  • O. Olaku, MD
  • Y. Pommier, MD
  • B. Ryan, PhD
  • J. Schiller, PhD
  • A. Simeonov, PhD
  • J. Smith, MD
  • E. Szabo, MD
  • M. Verma, PhD
  • J. Wei, PhD
  • F. Zia, MD

Date

Sept. 5 

Sept. 11

Sept. 25

Oct. 2

Oct. 10 

Oct. 17

Oct. 23

Oct. 30

Nov. 6

Nov. 14

Nov. 20

Nov. 27

Dec. 4


4 PM Lecture (links to notes)

Introduction

Clinical Trials

Immune Checkpoint

Prostate Cancer

Radiation Oncology

Lymphoma

Breast Cancer

Epidemiology

Cervical Cancer

NSCLC

Functional Genomics

Epigenetics

Pancreatic Cancer

 


5 PM Lecture

Imaging of Cancer

Precision Medicine

Ovarian Cancer

TGF beta

Topoisomerase

Small Molecules

SCLC

Health Disparities

Genomics

HSP 90 Chaperone

HIV

Case Reports

Nanotechnology